Analysts Set Kinaxis Inc. (TSE:KXS) PT at C$199.44

Kinaxis Inc. (TSE:KXSGet Free Report) has earned an average rating of “Moderate Buy” from the eight research firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is C$196.56.

Several equities research analysts have commented on the company. National Bankshares dropped their target price on Kinaxis from C$250.00 to C$225.00 and set an “outperform” rating on the stock in a report on Friday, March 1st. Scotiabank reduced their price objective on shares of Kinaxis from C$220.00 to C$200.00 and set an “outperform” rating for the company in a research note on Friday, March 1st. Eight Capital dropped their target price on shares of Kinaxis from C$230.00 to C$190.00 and set a “buy” rating on the stock in a research note on Friday, March 1st. Royal Bank of Canada reduced their price target on shares of Kinaxis from C$220.00 to C$200.00 and set an “outperform” rating for the company in a research report on Friday, March 1st. Finally, Stifel Nicolaus lowered their price objective on Kinaxis from C$235.00 to C$215.00 and set a “buy” rating on the stock in a research report on Friday, March 1st.

View Our Latest Analysis on Kinaxis

Kinaxis Stock Up 1.5 %

Shares of Kinaxis stock opened at C$151.10 on Friday. Kinaxis has a 1 year low of C$129.13 and a 1 year high of C$191.51. The company has a debt-to-equity ratio of 11.91, a current ratio of 2.53 and a quick ratio of 2.29. The company has a 50-day moving average of C$150.12 and a 200 day moving average of C$151.94. The firm has a market cap of C$4.29 billion, a price-to-earnings ratio of 209.86, a PEG ratio of 3.60 and a beta of 0.77.

Kinaxis (TSE:KXSGet Free Report) last released its earnings results on Wednesday, May 8th. The company reported C$0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of C$0.30 by C$0.06. Kinaxis had a net margin of 3.38% and a return on equity of 3.42%. The firm had revenue of C$160.93 million during the quarter, compared to analyst estimates of C$158.33 million. As a group, sell-side analysts anticipate that Kinaxis will post 2.8913676 earnings per share for the current fiscal year.

Insider Buying and Selling at Kinaxis

In related news, Senior Officer Stefanie Ann Gordish sold 214 shares of Kinaxis stock in a transaction on Wednesday, May 8th. The stock was sold at an average price of C$150.24, for a total value of C$32,152.34. Following the completion of the sale, the insider now owns 287 shares of the company’s stock, valued at C$43,120.20. In other news, Senior Officer Stefanie Ann Gordish sold 214 shares of the stock in a transaction that occurred on Wednesday, May 8th. The shares were sold at an average price of C$150.24, for a total value of C$32,152.34. Following the transaction, the insider now owns 287 shares in the company, valued at approximately C$43,120.20. Also, Senior Officer James Alexander Hollingworth sold 875 shares of the firm’s stock in a transaction that occurred on Tuesday, May 21st. The stock was sold at an average price of C$155.82, for a total transaction of C$136,345.74. Following the completion of the transaction, the insider now directly owns 745 shares in the company, valued at approximately C$116,088.66. In the last ninety days, insiders sold 34,650 shares of company stock worth $5,253,452. Insiders own 1.22% of the company’s stock.

About Kinaxis

(Get Free Report

Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. It offers RapidResponse, a cloud-based platform, which provides advanced planning, sales and operation planning, supply and demand planning, inventory management, and command and control center services.

Recommended Stories

Analyst Recommendations for Kinaxis (TSE:KXS)

Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.